Medication info
Actonel EC Tablets 35 Milligrams (Risedronate Sodium 2.5 Hydrate)

Actonel EC Tablets 35 Milligrams (Risedronate Sodium 2.5 Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Risedronate Sodium 2.5 Hydrate›35mg / 1 tablet
Manufacturer / importer
Yuyu Pharma
Appearance
Oval film-coated tablet colored yellow with 'EC 35' engraved on one side
Packaging
4 tablets/box
Approval status
Active

MFDS item code 201205259 · Approved 2012.05.31 · Insurance code 644503330

Summary

Main use
Treatment of osteoporosis in postmenopausal women
Who takes it
Adults · Children
Adult dose
Adults: Administer 35 mg of risedronate sodium orally once weekly in the morning, regardless of meals. Older adults: No dose adjustment is necessary in older adults (over 60 years of age). Patients with renal impairment: No dose adjustment is necessary in patients with a creatinine clearance of 30 mL/min or greater. This drug is contraindicated in patients with severe renal impairment and a creatinine clearance of less than 30 mL/min. ○ To help this drug reach the stomach easily and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170 ∼ 230 mL). Taking this drug with other beverages, including mineral water, may reduce its absorption. This drug must not be chewed or sucked because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking it. ○ If a patient forgets to take this drug on the scheduled day, take it the next morning when remembered. Resume taking the next dose on the originally scheduled day. Do not take 2 tablets on the same day.
Child dose
The safety and efficacy of this drug in children under 18 years of age have not been established.

Ingredients

Importer
Yuyu Pharma

Efficacy & effects

Treatment of osteoporosis in postmenopausal women

  • Osteoporosis
View approved original text

This medication is used for the treatment of osteoporosis in postmenopausal women. It improves the reduction in bone density caused by menopause and decreases the risk of fractures. Continuous use helps maintain and strengthen bone health.

How to take

Adult dose

Adults: Administer 35 mg of risedronate sodium orally once weekly in the morning, regardless of meals. Older adults: No dose adjustment is necessary in older adults (over 60 years of age). Patients with renal impairment: No dose adjustment is necessary in patients with a creatinine clearance of 30 mL/min or greater. This drug is contraindicated in patients with severe renal impairment and a creatinine clearance of less than 30 mL/min. ○ To help this drug reach the stomach easily and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170 ∼ 230 mL). Taking this drug with other beverages, including mineral water, may reduce its absorption. This drug must not be chewed or sucked because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking it. ○ If a patient forgets to take this drug on the scheduled day, take it the next morning when remembered. Resume taking the next dose on the originally scheduled day. Do not take 2 tablets on the same day.

Child dose

The safety and efficacy of this drug in children under 18 years of age have not been established.

Precautions

This medication may irritate the mucosa of the esophagus and stomach, so patients with gastrointestinal conditions such as esophagitis or gastric ulcer should take it with caution. It must be taken with a sufficient amount of water while sitting or standing, and patients should not lie down immediately after taking it. If symptoms such as difficulty swallowing, heartburn, or pain behind the sternum occur, the medication should be discontinued immediately and a doctor should be consulted. Patients with esophageal abnormalities, hypocalcemia, pregnant or nursing women, and those with severe renal impairment should not take this medication. Patients with upper gastrointestinal disease should use this medication cautiously and strictly follow the administration guidelines. It is important to ensure adequate intake of calcium and vitamin D during treatment, and the timing of calcium supplements or antacids should be adjusted as they may interfere with the absorption of this medication. Rare adverse effects such as osteonecrosis of the jaw have been reported, so patients, especially cancer patients or those with poor oral hygiene, should receive a dental examination prior to treatment. If taking this medication for a long time, if pain occurs in the thigh or pelvic region, it may indicate an atypical fracture, and the patient should inform their doctor. Women who are pregnant or may become pregnant should avoid taking this medication, and nursing mothers should either discontinue its use or stop breastfeeding. Overdose may result in hypocalcemia, so caution should be taken to avoid excessive intake, and in case of overdose, immediate consultation with medical personnel is advised. This medication should be kept out of the reach of children and should not be transferred to another container.

Side effects

  • esophagitis
  • esophageal ulcer
  • esophageal erosion
  • esophageal obstruction
  • esophageal perforation
  • bleeding
  • nasopharyngitis
  • influenza
  • urinary tract infection
  • bronchitis
Show 47 more
  • upper respiratory infection
  • pharyngitis
  • cystitis
  • gastroenteritis
  • shingles
  • sinusitis
  • diarrhea
  • abdominal pain
  • dyspepsia
  • constipation
  • vomiting
  • nausea
  • epigastric pain
  • hemorrhoids
  • gastroesophageal reflux disease
  • hiatal hernia
  • arthralgia
  • low back pain
  • limb pain
  • musculoskeletal pain
  • osteoarthritis
  • tendinitis
  • muscle rigidity
  • cervical pain
  • falls
  • bruising
  • dizziness
  • headache
  • sciatica
  • hypertension
  • allergic dermatitis
  • fatigue
  • elevated parathyroid hormone levels
  • cardiac disorders
  • cough
  • hypercholesterolemia
  • anemia
  • depression
  • cataract
  • iritis
  • uveitis
  • jaw osteonecrosis
  • external auditory canal osteonecrosis
  • vascular edema
  • generalized rash
  • spherical skin reaction
  • eye pain

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is advisable to maintain a storage temperature between 1 to 30 degrees Celsius to ensure the efficacy and safety of the medication over time.

Appearance and packaging

Appearance

Oval film-coated tablet colored yellow with 'EC 35' engraved on one side

Package unit

4 tablets/box

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.